HIVE Blockchain Technologies (NASDAQ:HIVE) board approved to effect a share consolidation of its shares at the ratio of 1-for-5, effective May.24. The objective of the share consolidation is to efficiently allocate shareholder capital. The company shares will trade on the TSXV and Nasdaq on a post-Consolidation basis under the same symbol, effective May 24, 2022. The consolidation will reduce the number of shares issued and outstanding from ~411.21M to ~82.24M shares. Consequently, the number of listed HIVE Warrants outstanding shall not be altered; however holders of HIVE Warrants will be entitled to receive one post-Share consolidation common share upon exercising five HIVE Warrants upon the payment of an adjusted price of CAD$30.00.
are necessary for technical reasons. Without them, this website may not function properly.
are necessary for specific functionality on the website. Without them, some features may be disabled.
allow us to analyse website use and to improve the visitor's experience.
allow us to personalise your experience and to send you relevant content and offers, on this website and other websites.